These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28217869)

  • 1. Reasons for Not Participating in Scleroderma Patient Support Groups: A Cross-Sectional Study.
    Gumuchian ST; Delisle VC; Peláez S; Malcarne VL; El-Baalbaki G; Kwakkenbos L; Jewett LR; Carrier ME; Pépin M; Thombs BD;
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):275-283. PubMed ID: 28217869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for non-participation in scleroderma support groups.
    Delisle VC; Gumuchian ST; Pelaez S; Malcarne VL; El-Baalbaki G; Körner A; Hudson M; Baron M; Thombs BD;
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):56-62. PubMed ID: 26950221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey.
    Gumuchian ST; Delisle VC; Kwakkenbos L; Pépin M; Carrier ME; Malcarne VL; Peláez S; El-Baalbaki G; Thombs BD;
    Disabil Rehabil; 2019 Apr; 41(8):974-982. PubMed ID: 29254393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys.
    Kwakkenbos L; Carboni-Jiménez A; Carrier ME; Pépin M; Peláez S; Malcarne VL; El-Baalbaki G; Thombs BD;
    Disabil Rehabil; 2021 May; 43(9):1279-1286. PubMed ID: 31522575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Training and support needs of scleroderma support group facilitators: the North American Scleroderma Support Group Facilitators Survey.
    Delisle VC; Gumuchian ST; El-Baalbaki G; Körner A; Malcarne VL; Peláez S; Carrier ME; Pépin M; Thombs BD;
    Disabil Rehabil; 2019 Oct; 41(20):2477-2482. PubMed ID: 29696997
    [No Abstract]   [Full Text] [Related]  

  • 6. Reasons for attending support groups and organizational preferences: A replication study using the North American Scleroderma Support Group Survey.
    Pépin M; Kwakkenbos L; Carrier ME; Peláez S; El-Baalbaki G; Malcarne VL; Thombs BD;
    J Scleroderma Relat Disord; 2019 Oct; 4(3):173-186. PubMed ID: 35382506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the nominal group technique to identify stakeholder priorities and inform survey development: an example with informal caregivers of people with scleroderma.
    Rice DB; Cañedo-Ayala M; Turner KA; Gumuchian ST; Malcarne VL; Hagedoorn M; Thombs BD;
    BMJ Open; 2018 Mar; 8(3):e019726. PubMed ID: 29500214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.
    Jewett LR; Hudson M; Haythornthwaite JA; Heinberg L; Wigley FM; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1779-86. PubMed ID: 20665750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study.
    Riehm KE; Kwakkenbos L; Carrier ME; Bartlett SJ; Malcarne VL; Mouthon L; Nielson WR; Poiraudeau S; Nielsen K; Baron M; Frech T; Hudson M; Pope J; Sauve M; Suarez-Almazor ME; Wigley FM; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1195-200. PubMed ID: 26619042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The educational needs of people with systemic sclerosis: a cross-sectional study using the Dutch version of the Educational Needs Assessment Tool (D-ENAT).
    Schouffoer A; Ndosi ME; Vliet Vlieland TP; Meesters JJ
    Rheumatol Int; 2016 Feb; 36(2):289-94. PubMed ID: 26321625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Support Groups in Scleroderma.
    Rice DB; Thombs BD
    Curr Rheumatol Rep; 2019 Feb; 21(4):9. PubMed ID: 30790067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the COVID-19 Fears Questionnaires for Chronic Medical Conditions: A Scleroderma Patient-centered Intervention Network COVID-19 Cohort study.
    Wu Y; Kwakkenbos L; Henry RS; Tao L; Harb S; Bourgeault A; Carrier ME; Levis B; Sun Y; Bhandari PM; Carboni-Jiménez A; Gagarine M; He C; Krishnan A; Negeri ZF; Neupane D; Mouthon L; Bartlett SJ; Benedetti A; Thombs BD; ;
    J Psychosom Res; 2020 Dec; 139():110271. PubMed ID: 33096402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a partially nested randomized controlled trial to evaluate the effectiveness of the Scleroderma Patient-centered Intervention Network Support Group Leader EDucation (SPIN-SSLED) Program.
    Thombs BD; Aguila K; Dyas L; Carrier ME; Fedoruk C; Horwood L; Cañedo-Ayala M; Sauvé M; Kwakkenbos L; Malcarne VL; El-Baalbaki G; Peláez S; Connolly K; Hudson M; Platt RW;
    Trials; 2019 Dec; 20(1):717. PubMed ID: 31831073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmet Workplace Support Needs and Lost Productivity of Workers With Systemic Sclerosis: A Path Analysis Study.
    Jetha A; Johnson SR; Gignac MAM
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):423-431. PubMed ID: 31841266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample.
    Leavens A; Patten SB; Hudson M; Baron M; Thombs BD;
    Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1195-201. PubMed ID: 22438281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives.
    Stubbs LA; Ferry AM; Guffey D; Loccke C; Wade EM; Pour P; Ardalan K; Chira P; Ganske IM; Glaser D; Higgins G; Luca N; Moore KF; Sivaraman V; Stewart K; Vasquez-Canizares N; Hunt RD; Maricevich RS; Torok KS; Li SC;
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):39. PubMed ID: 37098622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.
    Merz EL; Kwakkenbos L; Carrier ME; Gholizadeh S; Mills SD; Fox RS; Jewett LR; Williamson H; Harcourt D; Assassi S; Furst DE; Gottesman K; Mayes MD; Moss TP; Thombs BD; Malcarne VL;
    BMJ Open; 2018 Mar; 8(3):e018641. PubMed ID: 29511009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of the Body Concealment Scale for Scleroderma.
    Jewett LR; Malcarne VL; Kwakkenbos L; Harcourt D; Rumsey N; Körner A; Steele RJ; Hudson M; Baron M; Haythornthwaite JA; Heinberg L; Wigley FM; Thombs BD;
    Arthritis Care Res (Hoboken); 2016 Aug; 68(8):1158-65. PubMed ID: 26663624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "It's Not Me, It's Not Really Me." Insights From Patients on Living With Systemic Sclerosis: An Interview Study.
    Sumpton D; Thakkar V; O'Neill S; Singh-Grewal D; Craig JC; Tong A
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1733-1742. PubMed ID: 28129486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Sclerosis and Perceptions of Quality in Primary Care.
    Toci AL; Hyer JM; Silver RM; Nietert PJ; Hant FN
    Am J Med Sci; 2016 May; 351(5):447-51. PubMed ID: 27140701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.